An Experimental Study: Benefits of Digoxin on Hepatotoxicity Induced by Methotrexate Treatment

Purpose. The aim of the study is to examine the possible therapeutic effects of a known cardiac glycoside, digoxin, on a rat model of MTX-induced hepatotoxicity. Methods. The study was conducted on twenty-four male rats. While eighteen rats received a single dose of 20 mg/kg MTX to obtain an injured...

Full description

Saved in:
Bibliographic Details
Main Authors: Banu Taskin, Mümin Alper Erdoğan, Gürkan Yiğittürk, Sibel Alper, Oytun Erbaş
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Gastroenterology Research and Practice
Online Access:http://dx.doi.org/10.1155/2021/6619844
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832547563264278528
author Banu Taskin
Mümin Alper Erdoğan
Gürkan Yiğittürk
Sibel Alper
Oytun Erbaş
author_facet Banu Taskin
Mümin Alper Erdoğan
Gürkan Yiğittürk
Sibel Alper
Oytun Erbaş
author_sort Banu Taskin
collection DOAJ
description Purpose. The aim of the study is to examine the possible therapeutic effects of a known cardiac glycoside, digoxin, on a rat model of MTX-induced hepatotoxicity. Methods. The study was conducted on twenty-four male rats. While eighteen rats received a single dose of 20 mg/kg MTX to obtain an injured liver model, six rats constituted the control group. Also, the eighteen liver toxicity model created rats were equally divided into two groups, one of which received digoxin 0.1 mg/kg/day digoxin (Group 1) and the other group (Group 2) was given saline (% 0.9NaCl) with a dose of 1 ml/kg/day for ten days. Following the trial, the rats were sacrificed to harvest blood and liver tissue samples to determine blood and tissue MDA, serum ALT, plasma TNF-α, TGF-β, IL-6, IL-1-Beta, and PTX3 levels. Results. MTX’s structural and functional hepatotoxicity was observable and evidenced by relatively worse histopathological scores and increased biochemical marker levels. Digoxin treatment significantly reduced the liver enzyme ALT, plasma TNF-α, TGF-β, PTX3, and MDA levels and decreased histological changes in the liver tissue with MTX-induced hepatotoxicity in the rat model. Conclusion. We suggest that digoxin has an anti-inflammatory and antihepatotoxic effect on the MTX-induced liver injury model.
format Article
id doaj-art-389d3ec6e17b4f0a973c8907a7d6a429
institution Kabale University
issn 1687-630X
language English
publishDate 2021-01-01
publisher Wiley
record_format Article
series Gastroenterology Research and Practice
spelling doaj-art-389d3ec6e17b4f0a973c8907a7d6a4292025-02-03T06:44:03ZengWileyGastroenterology Research and Practice1687-630X2021-01-01202110.1155/2021/6619844An Experimental Study: Benefits of Digoxin on Hepatotoxicity Induced by Methotrexate TreatmentBanu Taskin0Mümin Alper Erdoğan1Gürkan Yiğittürk2Sibel Alper3Oytun Erbaş4Department of DermatologyDepartment of PhysiologyDepartment of Histology and EmbryologyDepartment of DermatologyDepartment of PhysiologyPurpose. The aim of the study is to examine the possible therapeutic effects of a known cardiac glycoside, digoxin, on a rat model of MTX-induced hepatotoxicity. Methods. The study was conducted on twenty-four male rats. While eighteen rats received a single dose of 20 mg/kg MTX to obtain an injured liver model, six rats constituted the control group. Also, the eighteen liver toxicity model created rats were equally divided into two groups, one of which received digoxin 0.1 mg/kg/day digoxin (Group 1) and the other group (Group 2) was given saline (% 0.9NaCl) with a dose of 1 ml/kg/day for ten days. Following the trial, the rats were sacrificed to harvest blood and liver tissue samples to determine blood and tissue MDA, serum ALT, plasma TNF-α, TGF-β, IL-6, IL-1-Beta, and PTX3 levels. Results. MTX’s structural and functional hepatotoxicity was observable and evidenced by relatively worse histopathological scores and increased biochemical marker levels. Digoxin treatment significantly reduced the liver enzyme ALT, plasma TNF-α, TGF-β, PTX3, and MDA levels and decreased histological changes in the liver tissue with MTX-induced hepatotoxicity in the rat model. Conclusion. We suggest that digoxin has an anti-inflammatory and antihepatotoxic effect on the MTX-induced liver injury model.http://dx.doi.org/10.1155/2021/6619844
spellingShingle Banu Taskin
Mümin Alper Erdoğan
Gürkan Yiğittürk
Sibel Alper
Oytun Erbaş
An Experimental Study: Benefits of Digoxin on Hepatotoxicity Induced by Methotrexate Treatment
Gastroenterology Research and Practice
title An Experimental Study: Benefits of Digoxin on Hepatotoxicity Induced by Methotrexate Treatment
title_full An Experimental Study: Benefits of Digoxin on Hepatotoxicity Induced by Methotrexate Treatment
title_fullStr An Experimental Study: Benefits of Digoxin on Hepatotoxicity Induced by Methotrexate Treatment
title_full_unstemmed An Experimental Study: Benefits of Digoxin on Hepatotoxicity Induced by Methotrexate Treatment
title_short An Experimental Study: Benefits of Digoxin on Hepatotoxicity Induced by Methotrexate Treatment
title_sort experimental study benefits of digoxin on hepatotoxicity induced by methotrexate treatment
url http://dx.doi.org/10.1155/2021/6619844
work_keys_str_mv AT banutaskin anexperimentalstudybenefitsofdigoxinonhepatotoxicityinducedbymethotrexatetreatment
AT muminalpererdogan anexperimentalstudybenefitsofdigoxinonhepatotoxicityinducedbymethotrexatetreatment
AT gurkanyigitturk anexperimentalstudybenefitsofdigoxinonhepatotoxicityinducedbymethotrexatetreatment
AT sibelalper anexperimentalstudybenefitsofdigoxinonhepatotoxicityinducedbymethotrexatetreatment
AT oytunerbas anexperimentalstudybenefitsofdigoxinonhepatotoxicityinducedbymethotrexatetreatment
AT banutaskin experimentalstudybenefitsofdigoxinonhepatotoxicityinducedbymethotrexatetreatment
AT muminalpererdogan experimentalstudybenefitsofdigoxinonhepatotoxicityinducedbymethotrexatetreatment
AT gurkanyigitturk experimentalstudybenefitsofdigoxinonhepatotoxicityinducedbymethotrexatetreatment
AT sibelalper experimentalstudybenefitsofdigoxinonhepatotoxicityinducedbymethotrexatetreatment
AT oytunerbas experimentalstudybenefitsofdigoxinonhepatotoxicityinducedbymethotrexatetreatment